Osaic Holdings
FBLG icon

Osaic Holdings’s FibroBiologics FBLG Stock Holding History

Osaic Holdings’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.28K Buy
2,404
+2,250
+1,461% +$2.61K ﹤0.01% 7238
2026
Q1 		$203 Sell
154
-146
-49% -$868 ﹤0.01% 7556
2025
Q4 		$1.32K Sell
300
-100
-25% -$704 ﹤0.01% 7200
2025
Q3 		$4.82K Hold
400
– – ﹤0.01% 6764
2025
Q2 		$4.96K Buy
400
+125
+45% +$2.25K ﹤0.01% 6546
2025
Q1 		$4.95K Sell
275
-1,466
-84% -$41.9K ﹤0.01% 6184
2024
Q4 		$69.6K Sell
1,741
-904
-34% -$48.5K ﹤0.01% 4450
2024
Q3 		$163K Hold
2,645
– – ﹤0.01% 3824
2024
Q2 		$264K Buy
+2,645
New +$505K ﹤0.01% 3312

Other funds holding FBLG

CFP
Cascade Financial Partners San Diego, California $1.15B AUM 33.6% 1-Year Est. Return
FEG
Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Osaic Holdings's FBLG Position: Q2 2026 in Review

Osaic Holdings increased its FibroBiologics (FBLG) stake by 1,461% in Q2 2026, buying an estimated $2.61K and bringing the position to 2,404 shares worth $2.28K. The position accounts for ﹤0.01% of the portfolio, ranked #7238.

Osaic Holdings first reported a position in FBLG in Q2 2024 and has held it in 9 quarters since. The position peaked at $264K in Q2 2024. 16 funds tracked by Wall St. Rank hold FBLG as of Q2 2026.

  • Osaic Holdings held 2,404 shares of FibroBiologics worth $2.28K as of Q2 2026.
  • Osaic Holdings bought 2,250 FibroBiologics shares in Q2 2026, an estimated $2.61K.
  • FibroBiologics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7238 holding.
  • Osaic Holdings first reported a position in FibroBiologics in Q2 2024 and has held it in 9 quarters since.
  • Osaic Holdings's FibroBiologics position peaked at $264K in Q2 2024.
  • 16 funds tracked by Wall St. Rank held FibroBiologics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.